The most substantial impact comes from tariffs against China and retaliatory tariffs from China, said Joseph Wolk, Johnson & Johnson's chief financial officer, in a conference call with analysts following the company's latest earnings results.
Johnson & Johnson expects $400 million in tariff-related costs, mostly related to China
→
"It's a very robust, 45,000-person study across eight countries in three different continents," he said. "We do have some of these new strains potentially captured in our data as we had sites in South Africa as well as Brazil. So we'll let the scientists do their work there."
Limited supply of coronavirus vaccine poses problem for Joe Biden's massive distribution plan
→
